Menzo J E Havenga

Title: Menzo J E Havenga: Innovator in Recombinant Adenoviruses

Introduction

Menzo J E Havenga is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant adenoviruses. With a total of two patents to his name, his work has implications for medical treatments and vaccine development.

Latest Patents

Havenga's latest patents focus on recombinant adenoviruses and their uses. These adenoviruses are derived from simian (rhesus) sources, characterized by low seroprevalence and high immunogenicity. This makes them particularly effective when expressing antigenic polypeptides. His patents also detail methods for producing these adenoviruses and outline treatment methods for diseases through the administration of adenoviral vectors to subjects, including humans.

Career Highlights

Menzo J E Havenga is affiliated with Beth Israel Deaconess Medical Center, Inc., where he continues to advance his research. His work is pivotal in the ongoing exploration of adenoviral vectors for therapeutic applications.

Collaborations

Havenga has collaborated with esteemed colleagues such as Dan H Barouch and Peter Abbink. These partnerships enhance the scope and impact of his research in the field of recombinant adenoviruses.

Conclusion

Menzo J E Havenga's innovative work in recombinant adenoviruses positions him as a key figure in biotechnology. His contributions are vital for the development of new medical treatments and vaccines.